Partilhar
Informação da revista
Artigos originais
Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial
Guy F.A. Prado Jr, Alexandre A.C. Abizaid, George C. Meireles, Rogério Sarmento-Leite, Mauricio Prudente, Marcelo Cantarelli, Adriano D. Dourado, Jose Mariani Jr, ... Pedro A. Lemos
Rev Port Cardiol. 2021;40:71-6
Open access
Artigos Originais
Comentário editorial
The third generation of drug-eluting stents: Reassuring data while we wait for the next one
Sergio Bravo Baptista
Rev Port Cardiol. 2021;40:77-80
Open access
Five years of Stent for Life in Portugal
Hélder Pereira, Rita Calé, Ernesto Pereira, Sofia Mello, Sílvia Vitorino, Pedro Jerónimo de Sousa, Sílvia Monteiro, Fausto J. Pinto, ... on behalf of the centers participating in the 'Stent for Life' Initiative Portugal
Rev Port Cardiol. 2021;40:81-90
Open access
Artigos Originais
Comentário editorial
Convergent initiatives to change the current situation
Rui Cruz Ferreira
Rev Port Cardiol. 2021;40:91-3
Open access
Long-term outcomes after radiofrequency catheter ablation of the atrioventricular node: The experience of a Portuguese tertiary center
Ana Mosalina Manuel, João Almeida, Paulo Fonseca, Joel Monteiro, Cláudio Guerreiro, Ana Raquel Barbosa, Pedro Teixeira, José Ribeiro, ... Pedro Braga
Rev Port Cardiol. 2021;40:95-103
Open access
Artigos Originais
Comentário editorial
Pace and ablate: The ultimate treatment for atrial fibrillation?
Pedro Carmo
Rev Port Cardiol. 2021;40:105-7
Open access
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal
Nuno Marques, Laetitia Gerlier, Mafalda Ramos, Helder Pereira, Sérgia Rocha, Ana Catarina Fonseca, Ana André, Ricardo Melo, Eduard Sidelnikov
Rev Port Cardiol. 2021;40:109-15
Open access
Artigos Originais
Comentário editorial
Indirect costs associated with cardiovascular events in Portugal
Miguel Gouveia
Rev Port Cardiol. 2021;40:117-8
Open access
Registo Nacional de Eletrofisiologia Cardíaca 2017‐2018
Nuno Cortez‐Dias, Pedro Silva Cunha, Francisco Moscoso Costa, Daniel Bonhorst, Mário M. Oliveira
Rev Port Cardiol. 2021;40:119-29
Open access
Artigos Originais
Comentário editorial
Portuguese electrophysiology: Consistent development
Francisco Bello Morgado
Rev Port Cardiol. 2021;40:131-2
Open access
Pequena comunicação
A preliminary identification of PIN1 SNP linkage in patients with coronary heart disease from Handan, China
Jing-Zhang Wang, Yu-Hua Zhang, Jing Bai, Wen-Tao Du, Xiang-Yang Zhang
Rev Port Cardiol. 2021;40:133-9
Open access
Caso clínico
Left ventricular pacing with a temporary pacemaker: Case report
Marta Tavares-Silva, Carla de Sousa, Vítor Araújo, Luís Adão, Gonçalo Pestana, Roberto Pinto, Filipe Macedo, Maria Júlia Maciel
Rev Port Cardiol. 2021;40:141.e1-141.e4
Open access
Imagem em cardiologia
Late challenges after full plastic jacket in spontaneous coronary dissection
Patrícia Marques-Alves, Manuel Oliveira-Santos, João Silva Marques, Lino Gonçalves
Rev Port Cardiol. 2021;40:143-4
Open access
Carta ao editor
Sobre o lado esquerdo – A importância da narrativa do coração para uma melhor compreensão da medicina
Francisco Rosário
Rev Port Cardiol. 2021;40:145
Open access
Conteúdo especial sobre COVID-19
- High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
- Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus
- Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?
- RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.